The HPV Vaccine Helps Prevent Cancers and Genital Warts
HPV stands for Human Papillomavirus, which is a very common family of viruses that are found in the skin and mucous membranes. There are over 140 types of HPV with 30-40 types that are commonly transmitted through sexual contact but most of them cause no symptoms and are temporary, 90% of all infections will go within 2 years.
While most people who get HPV will be unaware of it, for some people the effects of HPV can be devastating. HPV can cause genital warts and, far more seriously, a number of different types of cancer.
Despite the fact that HPV is the most common sexually transmitted infection, it seems that most of us knew little or nothing about it until the introduction of the HPV vaccine.
HPV Vaccination Programme for Cancer Prevention in Young Women
HPV vaccines (called Gardasil (Silgard) and Cervarix*) protect against two types of HPV (types 16 and 18) that are responsible for around 70% of all cervical cancers and for that reason they were initially approved for use with girls and young women between the ages of 9-26 for the prevention of cervical cancer, cancer of the vulva and vagina.
It has been argued that young males do not routinely need to be given the HPV vaccine, since clearly they are not at risk of cervical, vulva or vaginal cancer and vaccination of young women will help to increase what it is referred to as “herd immunity”. In other words, young women who have vad the HPV vaccine will not pass on the virus, so it will gradually decrease among males as well.
The Case for Offering Young Men the HPV Vaccine
Recently however, the FDA has approved the use of the HPV vaccine Gardasil for use with both males and females for the prevention of anal cancer and pre-cancerous lesions. This is in addition to its previously approved uses of preventing HPV caused cervical, vaginal and vulva cancer and also for the prevention of genital warts in both males and females.
HPV is associated with 90% of all anal cancer cases, with more women than men being diagnosed with this cancer. However among men, the disease is more prevalent among gay men who engage in anal sex and for this reason it is expected that more young gay men will choose to receive the HPV vaccine than other population groups.
There are other cancers that are associated with HPV and these are known as mouth and oropharyngeal cancers (cancers of the mouth and throat/cancers of the head and neck). In the past these cancers were most strongly associated with smoking and drinking, although HPV infection was also an acknowledged risk factor.
There is now evidence that suggests that incidences of oropharyngeal cancers are increasing and that the percentage of cases caused by HPV has risen from around 30% to over 70%. It also seems that men are increasingly at risk from HPV caused oropharyngeal cancers, with around 6 out of 7 of all new cases being seen in men. Oral sex with female partners is the most common way that HPV is transmitted to the mouth and throat.
HPV can also cause cancer of the penis.
HPV Vaccine Programs
Increasing numbers of male cancers cases caused by HPV may eventually make it cost effective to implement an HPV vaccination program for young males, as well as young females. Until such time young men will have either to pay for vaccination privately or hope that all their female partners have chosen to get have the HPV vaccine.
However, despite the HPV vaccine’s effectiveness at presenting extremely unpleasant and potentially lethal diseases, the number of young women in the US who have been vaccinated is currently only around 10%.
Ideally the HPV vaccine should be administered before a person becomes sexually active, although it is still worthwhile being vaccinated at a later stage.
*Cervarix protects against HPV types 16 and 18 which cause most HPV associated cancers. Gardasil (Silgard) protects against HPV types 6 and 11, which cause 90% of cases of genital warts and also protects against HPV types 16 and 18.